News
The pharma giant will pay $1.2 billion up-front for efimosfermin, with deal including potential success-based milestone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback